Keywords: regeneron, initiates, safety, tolerability, trial, phase, vegf

Regeneron initiates safety and tolerability trial Phase I trial of VEGF Trap

Article | 19 April 2004

Print This

The USA's Regeneron Pharmaceuticals has initiated a Phase I clinical trial in cancer designed to evaluate the safety and tolerability ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in